MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics' neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson's therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.
Часто задаваемые вопросы
В каком секторе работает Relief Therapeutics Holding SA (RLFTF)?
Relief Therapeutics Holding SA относится к сектору Здравоохранение.
Какова текущая цена акций Relief Therapeutics Holding SA (RLFTF)?
По последним данным, цена акций Relief Therapeutics Holding SA составляет 0,19 $, предыдущее закрытие — 0,19 $.
Выплачивает ли Relief Therapeutics Holding SA (RLFTF) дивиденды?
Нет, Relief Therapeutics Holding SA не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Relief Therapeutics Holding SA (RLFTF)?
У компании Relief Therapeutics Holding SA бета -0.325, что указывает на более низкую волатильность по сравнению с рынком в целом.
